Dreem

Dreem aims to provide effective sleep care to individuals and employers, as well as healthcare providers for their patients. Its mission is to become the global leader for screening, diagnosing and treating sleep disorders. Since the company's founding in 2014, it has raised $60 million from investors including Johnson & Johnson, accumulated 30 pat... ents, and put together a team of 90, split across in New York, Paris and Taipei. Along the way, it has created a scientific advisory board of four leading sleep doctors and neuroscientists, Prof. Raphael Heinzer, Dr. Emmanuel Mignot, Dr. Christof Koch and Prof. Russell Foster. A member of the American Sleep Research Society and the Digital Therapeutics Alliance, scientific rigor and research are cornerstones of the Dreem Company's unique approach. Dreem's hardware is used to study sleep in academic institutions and hospitals across the world, including the Stanford Sleep Center, Harvard Medical School, MIT, Washington State University St Louis Hospital and Cambridge University.Read More